ANI Pharmaceuticals Inc (ANIP)

NASDAQ
Currency in USD
68.95
+0.95(+1.40%)
Closed·
After Hours
68.950.00(0.00%)
·
ANIP Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
67.7969.99
52 wk Range
52.5070.48
Key Statistics
Edit
Prev. Close
68
Open
68.52
Day's Range
67.79-69.99
52 wk Range
52.5-70.48
Volume
239.52K
Average Vol. (3m)
310.96K
1-Year Change
3.85%
Book Value / Share
20.68
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANIP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
81.88
Upside
+18.75%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period
Show more

ANI Pharmaceuticals Inc Company Profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Employees
897

Compare ANIP to Peers and Sector

Metrics to compare
ANIP
Peers
Sector
Relationship
P/E Ratio
−69.5x15.4x−0.5x
PEG Ratio
0.310.020.00
Price / Book
3.5x2.4x2.6x
Price / LTM Sales
2.3x3.9x2.9x
Upside (Analyst Target)
21.9%148.0%60.8%
Fair Value Upside
Unlock18.1%10.8%Unlock

Analyst Ratings

7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 81.88
(+18.75% Upside)

Earnings

Latest Release
Feb 28, 2025
EPS / Forecast
1.63 / 1.45
Revenue / Forecast
190.60M / 175.12M
EPS Revisions
Last 90 days

People Also Watch

35.55
APAM
+3.98%
131.46
TFX
+1.79%
22.600
CPRX
+2.63%
31.54
OPCH
+0.93%

FAQ

What Is the ANI Pharma (ANIP) Stock Price Today?

The ANI Pharma stock price today is 68.95

What Stock Exchange Does ANI Pharma Trade On?

ANI Pharma is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for ANI Pharma?

The stock symbol for ANI Pharma is "ANIP."

What Is the ANI Pharma Market Cap?

As of today, ANI Pharma market cap is 1.40B.

What is ANI Pharma Earnings Per Share?

The ANI Pharma EPS is -1.04.

What Is the Next ANI Pharma Earnings Date?

ANI Pharma will release its next earnings report on May 09, 2025.

From a Technical Analysis Perspective, Is ANIP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.